Conversely, in the gender-unselected population, less than 2% of HER2-low breast tumors seemed to carry PVs in BRCA1/2 genes, and PVs in these genes were significantly more frequently identified in HER2-low patients [3]. This evidence concerns the gene ERBB2 and breast neoplasm.